United States · Series B startup

Who invested in Tune Therapeutics

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechGenomicsHealthcare

Funding summaryUpdated 26 Oct 2026

$175Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $175MJan 2025
Led by
New Enterprise Associates and Regeneron Venturesand 2 more
Investors
6 (4 led)
See who backed them

The rounds

  1. Jan 2025
    Series B$175M

    Reported by Hatteras Venture PartnersSEC filing: $182M sold, first sale Mar 2023

Founders and team

From Tune Therapeutics's own website: 3 founders, 5 on the team.

Akira MatsunoCo-Founder, President, CFO, COO
Charles GersbachCo-Founder
Fyodor UrnovCo-Founder
  • Blythe SatherSenior Vice President, Head of Research
  • Nathan YeeVice President, Portfolio Strategy & Operations
  • John McHutchisonCEO, Chairman of the Board
  • Derek JantzChief Scientific Officer
  • Heidi ZhangChief Development Officer

Everyone who backed them

New Enterprise AssociatesVC firm1round, led 1
Regeneron VenturesGrowth equity1round, led 1
YosemiteVC firm1round, led 1
Hevolution FoundationGrowth equity1round, led 1
Hatteras Venture PartnersVC firm1round
Mission BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tune Therapeutics

Who invested in Tune Therapeutics?

Tune Therapeutics's investors include New Enterprise Associates, Regeneron Ventures, Yosemite, Hevolution Foundation and Hatteras Venture Partners, and 1 more on record. New Enterprise Associates led its latest round.

How much has Tune Therapeutics raised?

Tune Therapeutics has raised $175M across 1 round since 2025.

When did Tune Therapeutics last raise?

Tune Therapeutics's most recent round was a Series B of $175M in Jan 2025, led by New Enterprise Associates.

What was Tune Therapeutics's biggest round?

Its most recent round, $175M in Jan 2025, is also its largest on record.

Who backed Tune Therapeutics first?

Tune Therapeutics's first round on record, in Jan 2025, was backed by New Enterprise Associates, Regeneron Ventures and Yosemite and 3 others.

What stage is Tune Therapeutics at?

Tune Therapeutics's latest named round is a Series B, in Jan 2025.

Where is Tune Therapeutics based?

Tune Therapeutics is based in the United States.

Who led Tune Therapeutics's rounds?

New Enterprise Associates led the Series B in 2025.

Companies like Tune Therapeutics

In the same sector, and raised in the last eighteen months.

Amogy$125M · Oct 2026Star Therapeutics$325M · Oct 2026Prolific Machines$105M · Oct 2026Promaxo$106M · Oct 2026AI$18M · Oct 2026Baba$40M · Oct 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app